The US Food and Drug Administration (FDA) has approved an improved stool collection kit of Geneoscopy’s RNA-based colorectal cancer (CRC) screening test, ColoSense. The new kit enhances user ...
ST. LOUIS, July 24, 2025--(BUSINESS WIRE)--Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, received FDA approval to ...
42 Technology (42T), FIND, the global alliance for diagnostics, and Rutgers University (Rutgers) have worked together to develop an innovative stool sample processing kit that has played a central ...
Building on the wide range of products available from DiaSorin for stool diagnostics, with each DiaSorin LIAISON® Ixt/Arrow™ instrument purchased during February 2014, DiaSorin is providing 2000€ ...
MILLIONS more people are benefiting from life-saving bowel screening compared to a decade ago – according to the NHS. Almost ...